IREN
IREN Limited
$27.73
+2.74% 2026-10-19
Financial Services
IRENSPY
1W
-20.3%
1M
-40.6%
3M
-31.0%
6M
-43.1%
YTD
-26.6%
1Y
-54.3%
Grades vs sector
Momentumno data–
Momentum
no data
Percentile within its GICS sector across the S&P 1500.
Growthno data–
Growth
no data
Percentile within its GICS sector across the S&P 1500.
Valueno data–
Value
no data
Percentile within its GICS sector across the S&P 1500.
Profitabilityno data–
Profitability
no data
Percentile within its GICS sector across the S&P 1500.
Revisionsno data–
Revisions
no data
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
Our models
Not held by any of our 3 live models right now.
Momentum Top 15
not ranked (outside this model's universe or screens)
Quality Growthnot ranked (outside this model's universe or screens)
Momentum Blendnot in the current book
Key stats
Market cap$10.9B
P/E (trailing)–
P/E (forward)-7.0
52-week range26.55 – 76.87
Revenue growth (YoY, latest qtr)-26.7%
Dividend yield0.00%
Analyst consensusBuy (18)
Mean price target$77.81 (+181%)
Valuation & fundamentals
Bottom line
No cash-flow valuation
Model read-out from the numbers below, not advice. Score +0 (DCF counts double).
▼Piotroski F-score2/9
▲Analyst target+181% (18 analysts)
Discounted cash flow
Trailing free cash flow is negative or missing, so a cash-flow DCF isn't meaningful by default. You can enter your own assumptions below.
Reverse DCFfor context, not a signal
A normal DCF guesses future cash flows and works out a price. A reverse DCF runs it backwards: it starts from today's price and asks how fast free cash flow would have to grow to justify it. It tells you what the market is assuming, not whether the stock is cheap or expensive, and it is not a buy or sell signal. Glossary
Trailing free cash flow is zero or negative, so there's no growth rate to solve for. The price is betting on a turnaround to positive cash flow.
Edit assumptions · recalculates instantly
Your value per share–
Free cash flow = operating cash flow − capital spending, trailing 12 months (FY to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 4.27 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.
Multiples vs sector
Forward EPS $-3.98 vs trailing $-2.22. Forward P/E uses analysts' next-12-month estimate.
Backlog (remaining performance obligations)
RPO
$5.1B
as of 2026-06-30
vs a year ago
–
YoY
× TTM revenue
7.21×
coverage
Contracted revenue not yet recognized, from SEC filings (XBRL tag RevenueRemainingPerformanceObligation).
Quality & financial health
Gross margin
68.9%
Operating margin
-148.0%
FCF margin
-127.0%
Net margin
-99.4%
Return on equity
-16.8%
Return on invested capital
-14.1%
Net debt / EBITDA
–
Current ratio
3.6×
Interest cover
-17.7×
Cash conversion (OCF/NI)
–
Piotroski F-score 2/9 · last two fiscal years
✗ Positive net income✓ Positive operating cash flow✗ Return on assets improved✓ Cash flow above net income✗ Long-term debt / assets fell✗ Current ratio improved✗ No share dilution✗ Gross margin improved✗ Asset turnover improved
Analysts
Mean target
$78
+181%
Analysts
18
Buy
Range
$37–$139
low – high
● price · ◆ mean target
Annual history
| FY | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2026 | $707.0M | $-702.6M | $-897.6M |
| 2025 | $501.0M | $86.9M | $-327.6M |
| 2024 | $187.2M | $-28.9M | $-89.6M |
| 2023 | $75.5M | $-171.8M | $-110.3M |
From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +110.8%.
Earnings
Next report: 2026-11-05 · during market · EPS est -0.66
EstimateActual (beat)Actual (miss)
| Report | EPS est | Actual | Surprise |
|---|---|---|---|
| 2026-08-27 | -0.45 | -0.25 | +44.1% |
| 2026-05-08 | -0.26 | -0.16 | +38.4% |
| 2026-02-05 | -0.25 | -0.03 | +88.4% |
| 2025-11-06 | 0.14 | 0.01 | -94.4% |
| 2025-08-28 | 0.22 | 0.21 | -2.5% |
| 2025-05-14 | 0.14 | 0.11 | -25.5% |
| 2025-02-12 | 0.06 | 0.09 | +35.7% |
| 2024-11-26 | -0.07 | -0.16 | -114.8% |
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2026-06-30 | $137.2M | -26.7% |
| 2026-03-31 | $144.8M | – |
| 2025-12-31 | $184.7M | – |
| 2025-09-30 | $240.3M | – |
| 2025-06-30 | $187.3M | – |
Analyst actions
B. Riley Securities
PT $91
2026-09-29 · main
Buy → BuyPT $91
Rothschild & Co
PT $40
2026-09-21 · init
→ NeutralPT $40
Northland Capital Markets
PT $99
2026-09-18 · init
→ OutperformPT $99
JP Morgan
PT $65
2026-09-14 · up
Underweight → OverweightPT $65
BTIG
PT $80
2026-09-14 · reit
Buy → BuyPT $80
Freedom Capital Markets
PT $58
2026-09-02 · main
Buy → BuyPT $58
News
Stock Market Today, Oct. 19: IREN Rallies on AI Infrastructure Sentiment Rebound
Nasdaq · 6h ago
Stock Market Today, Oct. 19: CoreWeave Rebounds on Goldman Sachs Buy Upgrade and $139 Price Target
Motley Fool · 7h ago
CoreWeave, Applied Digital, Nebius and IREN Stocks Rebound After AI Selloff
GuruFocus.com · 9h ago
AI Infrastructure Stocks Rally as Selloff Reverses: Applied Digital Jumps 8%, TeraWulf and IREN Rise 6%
24/7 Wall St. · 15h ago
Neocloud Stock Collapse: Buying Opportunity or Run for the Hills?
Motley Fool · Oct 17
CoreWeave Reverses Up As Wall Street Analysts Rush To Defend AI Stock.
Investor's Business Daily · Oct 15
Treasury Yields Dive For Wrong Reason As Neocloud Bonds Blow Up
Investor's Business Daily · Oct 15
Debt-Laden Neocloud Stocks Are Collapsing as Inflation Comes in Hot
Barchart · Oct 15
Stats refreshed 2026-10-19 19:03:14 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
coteau
Coteau Systematic StrategiesSystematic equity research and model portfolios.Coteau Systematic Strategies publishes research, model portfolios and tools. It does not manage money or offer investment advice. Model results are hypothetical. Data: Yahoo Finance (delayed), SEC EDGAR.